Rhode Peter
SEC CIK 1866276 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| HCWB | HCW Biologics Inc. | See Remarks | 77.5K | $100.0K | — | 4 | 2021-07-22 | 2023-12-11 |
Most active insiders at HCWB, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | GARRETT SCOTT T | Dir | $270.0K | — |
| 2 | Wong Hing C | CEO, Dir, 10% | $220.0K | — |
| 3 | Byam Rebecca | CFO | $20.0K | — |
| 4 | Flowers Lee | SVP of Business Development | $20.0K | — |
Rhode Peter made no open-market trades at HCWB in the last 12 months.
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-12-11 | 2023-12-11 | HCWB | HCW Biologics Inc. | Rhode Peter | See Remarks | M - OptEx | $0.14 | +14.0K | 77.5K | +22% | +$1,960 |
| D | 2023-11-20 | 2023-11-17 | HCWB | HCW Biologics Inc. | Rhode Peter | See Remarks | M - OptEx | $0.14 | +15.0K | 63.5K | +31% | +$2,100 |
| DM | 2022-01-19 | 2022-01-14 | HCWB | HCW Biologics Inc. | Rhode Peter | See Remarks | M - OptEx | $0.21 | +1,715 | 48.5K | +4% | +$360.08 |
| 2021-07-23 | 2021-07-22 | HCWB | HCW Biologics Inc. | Rhode Peter | See Remarks | P - Purchase | $8.00 | +12.5K | 46.8K | +36% | +$100.0K |
Purchase Sale Sale after option exercise All abbreviations